[HTML][HTML] Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
TS Fenske, PN Hari, J Carreras, MJ Zhang… - Biology of Blood and …, 2009 - Elsevier
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma
TS Fenske, PN Hari, J Carreras, MJ Zhang… - Biology of Blood and …, 2009 - cdr.lib.unc.edu
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
TS Fenske, PN Hari, J Carreras… - Biology of blood …, 2009 - pubmed.ncbi.nlm.nih.gov
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
[HTML][HTML] Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma
TS Fenske, PN Hari, J Carreras, MJ Zhang… - Biology of Blood and …, 2009 - astctjournal.org
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
TS Fenske, PN Hari, J Carreras… - Biology of Blood …, 2009 - scholars.northwestern.edu
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
[PDF][PDF] IMPACT OF PRE-TRANSPLANT RITUXIMAB ON SURVIVAL AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR DIFFUSE …
Biol Blood Marrow Transplant, 2009 - researchgate.net
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
[PDF][PDF] IMPACT OF PRE-TRANSPLANT RITUXIMAB ON SURVIVAL AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR DIFFUSE …
Biol Blood Marrow Transplant, 2009 - academia.edu
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
TS Fenske, PN Hari, J Carreras, MJ Zhang… - Biology of Blood and …, 2009 - europepmc.org
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
TS Fenske, PN Hari, J Carreras… - Biology of Blood …, 2009 - mdanderson.elsevierpure.com
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
TS Fenske, PN Hari, J Carreras… - Biology of Blood …, 2009 - experts.nebraska.edu
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens to
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …
treat diffuse large B cell lymphoma (DLBCL) has resulted in improved survival. Despite this …